Chapter 28 The glutamate synapse in neuropsychiatric disorders: Focus on schizophrenia and Alzheimer's disease
References (63)
Glutamate neurotoxicity and diseases of the nervous system
Neuron
(1988)- et al.
Multifocal brain damage induced by phencyclidine is augmented by pilocar-pine
Brain Res.
(1997) - et al.
Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity
Biol. Psychiatry
(1993) - et al.
α2 adrenergic agonists prevent MK-801 neurotoxicity
Neuropsychopharmacology
(1995) - et al.
Age specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?
Biol. Psychiatry
(1995) - et al.
N-methyl-D-aspartate mediated responses decrease with age in Fischer 344 rat brain
Neurobiology of Aging
(1991) - et al.
Neurodegeneration mediated by glutamate and β-amyloid peptide: A comparison and possible interaction
Brain Res.
(1995) - et al.
MK-801-induced neuronal damage in rats
Brain Res.
(1997) - et al.
Halothane prevents MK-801 neurotoxicity in the rat cingulate cortex
Neurosci. Lett.
(1995) - et al.
β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Brain Res.
(1990)
The NMDA receptor-antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans
Pain
(1992)
Age-related changes in excitatory amino acid receptors in two mouse strains
Neurobiology of Aging
(1993)
NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
Neuropsychopharmacology
(1996)
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors
Eur. J. Pharmacol.
(1990)
Neuropeptide Y and JO 1784, a selective γ ligand, alter intestinal ion transport through a common, haloperidol-sensitive site
Eur. J. Pharmacol.
(1990)
Dizocilpine binding to cerebral cortical membranes from developing and ageing mice
Mechanisms of Ageing & Development
(1995)
Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels
Neuroscience
(1994)
DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex
Brain Res.
(1995)
Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain
Neuroscience
(1997)
Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys
Neurobiology of Aging
(1991)
Phencyclidine, dizocilpine, and cerebrocortical neurons
Science
(1990)
Observations on the action of Sernyl – A new psychotropic drug
Can. Psychiatr. Assoc. J.
(1961)
Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
Arch. Gen. Psychiatry
(1991)
Retrosplenial region involvement in Alzheimer's Disease
Neurodegeneration
(1992)
Staging of Alzheimer's disease-related neurofibrillary changes
Neurobiology of Aging
(1995)
Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histological grading
Histopathology
(1981)
Excitotoxic cell death
Journal of Neurobiology
(1992)
Abnormal mental states induced by phencyclidine as a model of schizophrenia
Competitive and non-competitive NMDA antagonists induce similar limbic degeneration
Neuroreport
(1994)
Costimulation of muscarinic and non-NMDA glutamate receptors reproduces NMDA antagonist neurotoxicity
Soc. Neurosci. Abstr.
(1997)
Scrotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity
Neuro-psychopharmacology
(1998)
Cited by (143)
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
2023, Pharmacology Biochemistry and BehaviorA stable naked-eye colorimetric sensor for monitoring release of extracellular gamma-aminobutyric acid (GABA) neurotransmitter from SH-SY5Y cells
2022, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyCitation Excerpt :4-aminobutyric acid (GABA) is considered one of the primary inhibitory neurotransmitters [1] and plays a vital role in decreasing neuronal excitability [2]. Neurological and psychiatric disorders (e.g., epilepsy, schizophrenia, and Alzheimer’s disease) are accompanied by a change in the GABA level [3-10]. Hence, detecting the concentrations of neurotransmitters is essential in drug design and elucidation of the central nervous system.
Ketamine for post-traumatic stress disorders and it's possible therapeutic mechanism
2021, Neurochemistry InternationalPattern recognition of amino acids based on highly fluorescent SDS modified pyridyl thiazole derivative
2020, Sensors and Actuators, B: Chemical
Copyright © 1998 Academic Press Inc. Published by Elsevier B.V. All rights reserved.